Wecomput (中大唯信)

Beijing, China

Drug Discovery Drug Development Data Services Life Sciences

WeComput is dedicated to "computational technology driving innovative drug research and development." With a profound understanding of the innovative drug development process, WeComput integrates artificial intelligence, biophysics, and high-performance computing technologies to create a unique digital, intelligent and automated platform for drug molecule generation, design and simulation. This platform is poised to revolutionize traditional drug discovery methods and drive the research and development of innovative drugs such as antibodies, proteins, small molecules and mRNA. The parent company, Beijing Zhongda Weixin Technology Co., Ltd., was registered in 2015 and has been recognized as a national high-tech enterprise. In 2021, it received equity investment from Sequoia Capital and was selected as a senior member of the NVIDIA Inception program. To date, WeComput has served hundreds of clients worldwide, including numerous biopharmaceutical companies, universities, hospitals, and re

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Wecomput (中大唯信) on @MedStartr Today #DrugToxicity #DrugDevelopment #DrugDiscovery #DataServices #LifeSciencesBiopharma #MedMo #MedStartrVentures

https://www.medstartr.ai/s/MdbX4ZeCdVg

Get Involved in Wecomput (中大唯信)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2015
Website: www.wecomput.com/

Disease Areas

Drug Toxicity Drug Development

Technologies

Data AnalysisComputational BiologyMolecular ModelingDrug Design

🌐Website

What do you think of Wecomput (中大唯信)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.